NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
- Free cash flow, 2025
- $749M
- YoY, 2025
- +34.4%
- 5-year CAGR
- +28.0%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $749M | +34.4% |
| 2024 | $557M | +54.1% |
| 2023 | $362M | +12.0% |
| 2022 | $323M | +38.5% |
| 2021 | $233M | +7.1% |
| 2020 | $218M | +64.5% |
| 2019 | $132M | +72.7% |
| 2018 | $77M | — |
| 2017 | −$101M | — |
| 2016 | −$110M | — |
| 2015 | −$40M | — |
| 2014 | −$49M | — |
| 2013 | −$30M | — |
| 2012 | −$36M | — |
| 2011 | −$1.4M | — |
| 2010 | $50M | — |
| 2009 | −$53M | — |